BMC Cardiovascular Disorders

Table 3 Cardiovascular risk factors at baseline and follow-up in patients with Diabetes Mellitus¹

From: Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care

		Baseline			8 weeks			Difference²
		N	mean	± SD	N	mean	± SD	N	mean	± SD
Blood pressure
systolic	mmHg	1517	160.0	13.99	1489	134.1	11.2	1474	-25.9*	13.7
diastolic	mmHg	1517	93.4	8.46	1489	81.2	6.7	1474	-12.2*	9.0
Fasting plasma glucose
	mg/dL	1302	132.0	36.8	994	121.8	31.4	972	-10.8*	30.1
Waist circumference
men	cm	633	109.4	12.8	601	108.2	12.2	597	-1.3*	2.5
women	cm	570	100.6	14.7	530	99.5	13.6	526	-0.9*	2.7
Triglycerides
	mg/dL	1187	205.1	104.5	834	185.6	78.4	811	-23.3*	76.2
HDL Cholesterol
men	mg/dL	601	49.2	21.6	430	48.9	16.7	420	0.5**	14.36
women	mg/dL	558	54.0	19.0	373	54.0	17.7	361	2.0**	14.79

¹ diagnosis assigned by physician; ² difference versus baseline; statistical test applied: t-test; * p < 0.0001; ** p < 0.05. Adjusted for age.

Back to article page

ISSN: 1471-2261

Contact us

Submission enquiries: bmccardiovasculardisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com